PURPOSE: To perform a systematic literature review for critical evaluation of prevalence and
factors contributing to malnutrition in childhood cancer. METHODS: A systematic search …

The dramatic improvements seen in the outcome of paediatric patients with acute
lymphoblastic leukaemia (ALL) have led to increasing incorporation of L-asparaginase (L …

Doxorubicin, an anthracycline antibiotic, is a commonly used anticancer drug. In spite of its
widespread usage, its therapeutic effect is limited by its cardiotoxicity. On the cellular level …

Essentials• Hemostasis biomarkers impact thrombosis occurrence and survival in cancer
patients.• We performed a longitudinal analysis of hemostatic parameters in 112 cancer …

Patients undergoing treatment of acute lymphoblastic leukemia (ALL) are at risk for
thrombosis, caused in part by the use of l-asparaginase (L-ASP). Antithrombin (AT) …

Thrombotic complications have a significant impact on morbidity and mortality of
hematological cancer patients, therefore, in this setting, the issue of thromboprophylaxis to …

The occurrence of venous thromboembolism (VTE) in acute lymphocytic leukemia patients
receiving L-asparaginase therapy may cause significant morbidity, neurological sequela …

Background Invasive mucormycosis is a rare but frequently fatal fungal disease. The acute
and rapidly progressive evolution causes unfavourable outcome in 22%‐59% of patients …

Background Childhood acute lymphoblastic leukemia (ALL) survivors have increased risk of
obesity, metabolic alterations and cardiovascular disease (CVD). Vascular endothelial …

Venous thromboembolic (VTE) complications are common in patients with cancer and
represent the second cause of death in this disease. The risk of VTE varies according to the …